Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research.

Cybin Inc. Announces Positive End-Of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design | Psychedelic Invest

Cybin Inc. announced a positive End-of-Phase 2 meeting with the FDA for CYB003, its deuterated psilocybin analog for the adjunctive treatment of Major Depressive Disorder

March 14, 2024

Nearly a decade after recreational cannabis sales began in Colorado, Golden takes its first rip – The Cannabist

Related Articles GOLDEN — Seventeen months after voters in this city said yes to recreational cannabis sales — and nearly a decade after the first

May 3, 2023

Best inflatable paddleboards for every adventurer – The Cannabist

Which inflatable paddleboards are best? Paddleboarding is a fun water sport for people of all ages and abilities, but storing a solid paddleboard isn’t always

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.